Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Relationship of EPS, Antiparkinsonian Drugs, and TD

John M. Kane, MD, and Rebecca S. Roma, MD, discuss the relationship of extrapyramidal symptoms, antiparkinsonian drugs, and tardive dyskinesia.
John M. Kane, MD
Rebecca S. Roma, MD
Released: July 20, 2021

In this episode, John M. Kane, MD, and Rebecca S. Roma, MD, discuss clinical assessment of extrapyramidal symptoms (EPS), antiparkinsonian drugs, and tardive dyskinesia (TD). They review differentiating between TD and EPS, identify tools for diagnosing TD, and provide some important clinical pearls and evidence-based reasons for choosing different medications for treating EPS and TD.

Presenters:

John M. Kane, MD
Professor and Chairman
Department of Psychiatry
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Glen Oaks, New York

Rebecca S. Roma, MD
Medical Director
REACH, LLC
Pittsburgh, Pennsylvania

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences

Related Content

Slides from a presentation that educates clinicians on how to formulate an approach to treat patients with bipolar disorder.

person default Thomas L. Schwartz, MD Released: July 23, 2021

Slides from a presentation that educates clinicians on how to formulate an approach to diagnose patients with bipolar disorder.

Manpreet K. Singh, MD, MS Released: July 22, 2021

Clinical Care Options (CCO) commentary by Jonathan M. Meyer, MD, on VMAT2 inhibitors in TD and anticholinergic exacerbation of TD symptoms.

Jonathan M. Meyer, MD Released: July 8, 2021

Slides from a presentation that formulates an approach to diagnose patients with tardive dyskinesia.

Greg Mattingly, MD Released: June 21, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue